Written by Klarity Editorial Team
Published: Jul 17, 2026

Last updated: July 17, 2026
Humana Hawaii Quick Facts (2026): Humana offers Medicare Advantage (MA) plans only in Hawaii — no commercial or employer-sponsored plans. Plan administration falls under CMS 42 CFR Part 422, not Hawaii state insurance statutes. PBM: Humana Pharmacy Solutions (HPS). Hawaii state parity law (Haw. Rev. Stat. § 431M-1) does NOT apply — federal MHPAEA via CMS governs. Hawaii Prepaid Health Care Act (HRS § 393) does NOT apply. Hawaii EPCS law (HRS § 329-38.5) is entirely inapplicable to depression medications — all standard antidepressants are non-scheduled controlled substances, and Spravato (esketamine, Schedule III) is NOT subject to HRS § 329-38.5 (which covers Schedule II only). Dual-eligible (Medicaid + Medicare) members: contact Hawaii Med-QUEST at 1-800-316-8005.
If you are a Hawaii resident enrolled in a Humana Medicare Advantage plan and you or a loved one is managing depression, understanding your prescription and therapy benefits is an important first step. This guide explains how Humana’s MA plans in Hawaii may cover depression treatment, what the Humana Pharmacy Solutions (HPS) formulary typically includes, how prior authorization works, and how federal mental health parity rules protect you — all with the important caveat that coverage details vary by plan. Always verify your specific benefits before booking appointments or filling prescriptions.
See If You May Qualify for Online Depression Treatment →
Humana exited the commercial and individual health insurance market in most states, including Hawaii, and now operates exclusively through Medicare Advantage plans. In Hawaii, Humana typically offers plan types including:
Because Humana operates as a Medicare Advantage Organization (MAO) in Hawaii, all plan rules — including drug formulary, prior authorization, and mental health parity — are governed by CMS under 42 CFR Part 422, not by Hawaii state insurance law. This is a critical distinction for Hawaii residents accustomed to filing complaints with the Hawaii Insurance Division: for Humana MA plans, the regulatory body is CMS, not the state.
Important: Hawaii residents with Medicaid (Med-QUEST) coverage who are also enrolled in a Humana MA plan are considered dual-eligible members. Your benefits may coordinate differently. Contact Hawaii Med-QUEST at 1-800-316-8005 and Humana at 1-800-448-6262 to understand how your Medicaid benefits interact with your MA plan for depression treatment coverage.
Humana Pharmacy Solutions (HPS) administers the prescription drug benefit for Humana MA plans in Hawaii. The following table reflects typical HPS formulary tier placement for common depression medications. Actual tier placement and cost-sharing depend on your specific plan. Always verify coverage through your Humana online portal or by calling HPS at 1-800-379-0092.
| Medication | Drug Class | Schedule | Typical HPS Tier | PA Required? | EPCS (HRS § 329-38.5)? |
|---|---|---|---|---|---|
| Sertraline (generic Zoloft) | SSRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Escitalopram (generic Lexapro) | SSRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Fluoxetine (generic Prozac) | SSRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Paroxetine (generic Paxil) | SSRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Lexapro (brand) | SSRI (brand) | Non-scheduled | Tier 3–4 | Step therapy often required | Not applicable |
| Venlafaxine ER (generic Effexor XR) | SNRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Duloxetine (generic Cymbalta) | SNRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Effexor XR (brand) | SNRI (brand) | Non-scheduled | Tier 3–4 | Step therapy often required | Not applicable |
| Bupropion (generic Wellbutrin) | NDRI | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Mirtazapine (generic Remeron) | NaSSA | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Amitriptyline / Nortriptyline | TCA | Non-scheduled | Tier 1–2 | Rarely | Not applicable |
| Trintellix (vortioxetine) | SARI/multimodal | Non-scheduled | Tier 3–4 | PA likely required | Not applicable |
| Auvelity (dextromethorphan/bupropion) | NMDA antagonist | Non-scheduled | Tier 3–4 | PA likely required | Not applicable |
| Spravato (esketamine nasal spray) | NMDA antagonist | Schedule III | Specialty tier | PA + REMS required | NOT applicable — HRS § 329-38.5 covers Schedule II only |
Note: Tier placement and PA requirements are subject to change. Verify your plan’s specific 2026 formulary at Humana.com or by calling HPS at 1-800-379-0092.
While many generic antidepressants (SSRIs and SNRIs in generic form) typically do not require prior authorization under HPS, brand-name medications and newer agents like Trintellix and Auvelity often require prior authorization and may involve step therapy — meaning your provider may need to demonstrate that a generic equivalent was tried first.
How prior authorization typically works under Humana MA (CMS 42 CFR Part 422 timelines):
For Spravato specifically: Spravato is a specialty medication delivered only in a certified healthcare setting under the REMS (Risk Evaluation and Mitigation Strategy) program. PA is required in addition to REMS compliance. Your provider’s clinic must be REMS-certified. Coverage under HPS MA plans may be limited to in-network specialty pharmacies.
Hawaii’s Electronic Prescribing for Controlled Substances (EPCS) law — codified at Haw. Rev. Stat. § 329-38.5 — requires electronic prescribing for Schedule II controlled substances only. This is one of the narrower EPCS mandates in the United States.
For depression treatment in Hawaii, HRS § 329-38.5 is entirely inapplicable. Here is why, medication class by medication class:
In summary, no standard depression medication — including Spravato — triggers Hawaii’s EPCS requirement. Electronic prescribing may still be used as a clinical best practice, but it is not legally mandated for any antidepressant under HRS § 329-38.5.
Because Humana operates only Medicare Advantage plans in Hawaii, the Mental Health Parity and Addiction Equity Act (MHPAEA) applies through CMS federal enforcement — not through Hawaii’s state parity statute (Haw. Rev. Stat. § 431M-1 et seq.), which governs commercial insurers only.
Under CMS 42 CFR Part 422, Humana MA plans must:
What this means for depression coverage: If Humana applies step therapy for a brand antidepressant, that step therapy requirement must be no more restrictive than what applies to a comparable brand medication in a medical/surgical context. If you believe a PA denial or coverage restriction violates parity, you may file a complaint directly with CMS at 1-800-633-4227 or online at cms.gov.
Important distinction: Hawaii Insurance Division (1-808-586-2790) handles complaints for commercial/state-regulated plans. For Humana MA plans, contact CMS — the Hawaii state regulator does not have jurisdiction over Medicare Advantage.
Beyond prescription coverage, Humana MA plans in Hawaii typically cover behavioral health services for depression, including:
Coverage for therapy is subject to your plan’s in-network provider requirement. Humana’s online provider directory can help you locate in-network psychiatrists and therapists in Hawaii. Telehealth therapy visits are widely covered for MA enrollees in Hawaii under ongoing CMS telehealth flexibility provisions.
If you are enrolled in both Humana Medicare Advantage and Hawaii Medicaid (Med-QUEST), you are a dual-eligible member and may be enrolled in a Dual Eligible Special Needs Plan (D-SNP). Depression treatment coordination in this case involves both programs:
Medicaid Disclaimer: Medicaid eligibility and benefits are determined by the Hawaii Department of Human Services through the Med-QUEST Division. This content is not affiliated with or endorsed by the State of Hawaii. Contact Hawaii Med-QUEST at 1-800-316-8005 for the most current Medicaid benefit information.
Humana MA plans in Hawaii may cover treatment for a range of depressive disorders when medically necessary, including:
Coverage for each diagnosis is subject to medical necessity determination and plan-specific criteria. Your provider will need to document the diagnosis and treatment rationale.
Klarity Health connects patients across Hawaii with a network of 2,000+ licensed providers who specialize in mental health treatment, including depression. Klarity providers offer:
Coverage for Klarity Health visits through a Humana MA plan in Hawaii depends on whether Klarity providers are in-network with your specific plan. We recommend verifying your benefits and in-network status before your first visit.
Check If You May Qualify for Online Depression Treatment →
Humana MA plans in Hawaii typically cover generic antidepressants (SSRIs, SNRIs, bupropion, mirtazapine, TCAs) at Tier 1–2 with low or no cost-sharing. Brand antidepressants are generally Tier 3–4 and may require step therapy. Coverage specifics vary by plan — verify through HPS at 1-800-379-0092 or Humana.com.
No. Haw. Rev. Stat. § 329-38.5 applies to Schedule II controlled substances only. All standard antidepressants — including SSRIs, SNRIs, bupropion, mirtazapine, and TCAs — are non-scheduled, so the EPCS mandate does not apply. Spravato (esketamine) is Schedule III and is also not subject to Hawaii’s EPCS statute, which covers Schedule II only.
No. Haw. Rev. Stat. § 431M-1 et seq. applies to commercial insurers regulated under Hawaii state law. Because Humana operates exclusively through Medicare Advantage in Hawaii, federal MHPAEA enforced by CMS under 42 CFR Part 422 governs. You cannot file a § 431M-1 complaint with the Hawaii Insurance Division against a Humana MA plan — complaints go to CMS at 1-800-633-4227.
Spravato may be covered under HPS as a specialty-tier medication for treatment-resistant depression, but it requires prior authorization and REMS compliance. Both the prescribing provider’s clinic and the dispensing pharmacy must be REMS-certified. Spravato is administered in-clinic under medical supervision. Contact HPS at 1-800-379-0092 to verify specialty coverage and locate REMS-certified dispensing sites in Hawaii.
You have the right to appeal. Under CMS 42 CFR Part 422, the Humana MA appeals process is: (1) Redetermination by Humana/HPS; (2) Independent Review Entity (IRE); (3) Administrative Law Judge (ALJ) hearing; (4) Medicare Appeals Council review; (5) Federal District Court. You can also contact your State Health Insurance Assistance Program (SHIP) in Hawaii for free counseling — call 1-888-875-9229.
Klarity Health’s network of 2,000+ licensed providers includes psychiatrists and prescribers who treat depression via telehealth. Coverage depends on whether Klarity providers are in-network with your specific Humana MA plan in Hawaii. Contact Humana at 1-800-448-6262 to verify in-network status before your first appointment.
Disclaimer: This content is provided for general informational and educational purposes only and does not constitute medical or legal advice. Insurance coverage for depression treatment through Humana Medicare Advantage plans in Hawaii varies by plan, formulary year, and individual medical circumstances. Coverage descriptions reflect typical plan structures as of 2026 and may change. Always verify your specific benefits by contacting Humana directly at 1-800-448-6262 or reviewing your Evidence of Coverage document before scheduling treatment or filling prescriptions. Klarity Health is not affiliated with or endorsed by Humana Insurance Company or CMS.
Medicaid Disclaimer: This content is not affiliated with or endorsed by the State of Hawaii or the Hawaii Department of Human Services. Medicaid eligibility and benefits are administered by the Med-QUEST Division. Contact Hawaii Med-QUEST at 1-800-316-8005 for official information regarding your Medicaid benefits.
Find the right provider for your needs — select your state to find expert care near you.